Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.
Repair Biotechnologies has raised $5.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Repair Biotechnologies's investors include Longevitytech.fund, Grapeseed.Bio, Healthspan Capital, SENS Foundation, Thynk Capital.
Repair Biotechnologies is headquartered in Syracuse, United States.
Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading platform.
Repair Biotechnologies is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Repair Biotechnologies — Funding & Investors." VCBacked, November 25, 2025, https://www.vcbacked.co/company/repair-biotechnologies. Accessed August 16, 2026.
VCBacked. (2025). Repair Biotechnologies — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/repair-biotechnologies
{{cite web |title=Repair Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/repair-biotechnologies |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated